You are here

  • Home
  • Archive
  • Volume 26, Issue 4
  • High Efficacy and Low Toxicity of the Modified Docetaxel and Carboplatin Protocol in Patients with Recurrent Ovarian Cancer—A Phase 2 Cohort Study

Article metrics

Article menu
Download PDFPDF
Ovarian Cancer
High Efficacy and Low Toxicity of the Modified Docetaxel and Carboplatin Protocol in Patients with Recurrent Ovarian Cancer—A Phase 2 Cohort Study

 

Online download statistics by month:

Online download statistics by month: February 2019 to April 2024

AbstractFullPdf
Feb 2019602
Mar 20193600
Apr 20191601
May 20192400
Jun 20193801
Jul 20192700
Aug 20194900
Sep 20193000
Oct 20191901
Nov 20192700
Dec 20194603
Jan 20202500
Feb 20204201
Mar 2020800
Apr 20201200
May 20201800
Jun 20204401
Jul 20203000
Aug 20202200
Sep 20201800
Oct 20201601
Nov 2020800
Dec 20201200
Jan 20214401
Feb 20212701
Mar 20212600
Apr 2021200
Sep 2021302
Oct 20211000
Nov 20211003
Dec 20211200
Jan 20222401
Feb 20222000
Mar 20222801
Apr 20222800
May 20224400
Jun 20224001
Jul 20222600
Aug 20225200
Sep 20224400
Oct 20224200
Nov 20221400
Dec 20222400
Jan 2023900
Feb 20237001
Mar 20231100
Apr 20231400
May 2023600
Jun 20231200
Jul 20231000
Aug 20231200
Sep 20231000
Oct 20231600
Nov 20231400
Dec 20232200
Jan 20242401
Feb 20241000
Mar 20241200
Apr 20241600
Total1361023